Volume 45, Issue 1, Pages (January 2012)

Slides:



Advertisements
Similar presentations
Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repair by Luca Colnaghi, Mathew.
Advertisements

Volume 55, Issue 1, Pages (July 2014)
The Rb-Related p130 Protein Controls Telomere Lengthening through an Interaction with a Rad50-Interacting Protein, RINT-1  Ling-Jie Kong, Alison R. Meloni,
JNK1 Phosphorylation of Cdt1 Inhibits Recruitment of HBO1 Histone Acetylase and Blocks Replication Licensing in Response to Stress  Benoit Miotto, Kevin.
ASF1a Promotes Non-homologous End Joining Repair by Facilitating Phosphorylation of MDC1 by ATM at Double-Strand Breaks  Kyung Yong Lee, Jun-Sub Im, Etsuko.
Volume 47, Issue 3, Pages (August 2012)
Volume 13, Issue 3, Pages (October 2015)
Volume 54, Issue 1, Pages (April 2014)
Volume 44, Issue 4, Pages (November 2011)
Yu-Hsin Chiu, Jennifer Y. Lee, Lewis C. Cantley  Molecular Cell 
Volume 36, Issue 2, Pages (October 2009)
Volume 22, Issue 5, Pages (May 2012)
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Richard C. Centore, Stephanie A. Yazinski, Alice Tse, Lee Zou 
Feng Zhang, Jiazhong Shi, Chunjing Bian, Xiaochun Yu  Cell Reports 
Eun-Joo Kim, Jeong-Hoon Kho, Moo-Rim Kang, Soo-Jong Um  Molecular Cell 
Volume 45, Issue 5, Pages (March 2012)
Communication with the Exon-Junction Complex and Activation of Nonsense-Mediated Decay by Human Upf Proteins Occur in the Cytoplasm  Guramrit Singh, Steffen.
Coactivation of MEF2 by the SAP Domain Proteins Myocardin and MASTR
Nithya Raman, Elisabeth Weir, Stefan Müller  Molecular Cell 
TopBP1 Controls BLM Protein Level to Maintain Genome Stability
Volume 23, Issue 2, Pages (July 2006)
Coupling of Homologous Recombination and the Checkpoint by ATR
Volume 149, Issue 4, Pages (May 2012)
George-Lucian Moldovan, Boris Pfander, Stefan Jentsch  Molecular Cell 
Volume 15, Issue 6, Pages (September 2004)
Volume 29, Issue 4, Pages (February 2008)
Vanessa Brès, Tomonori Yoshida, Loni Pickle, Katherine A. Jones 
Volume 135, Issue 2, Pages (October 2008)
Andrew J. Deans, Stephen C. West  Molecular Cell 
Volume 66, Issue 4, Pages e5 (May 2017)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 48, Issue 4, Pages (November 2012)
Per Stehmeier, Stefan Muller  Molecular Cell 
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Volume 12, Issue 5, Pages (November 2003)
Volume 28, Issue 3, Pages (November 2007)
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Volume 59, Issue 3, Pages (August 2015)
Volume 23, Issue 5, Pages (May 2013)
The Prolyl Isomerase Pin1 Functions in Mitotic Chromosome Condensation
Volume 47, Issue 4, Pages (August 2012)
Volume 25, Issue 5, Pages (March 2007)
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Volume 54, Issue 6, Pages (June 2014)
Volume 24, Issue 6, Pages (December 2006)
Volume 24, Issue 18, Pages (September 2014)
Volume 16, Issue 2, Pages (February 2009)
Volume 15, Issue 1, Pages (July 2004)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Volume 47, Issue 3, Pages (August 2012)
The Genetic and Biochemical Basis of FANCD2 Monoubiquitination
Sebastian Rumpf, Stefan Jentsch  Molecular Cell 
Volume 29, Issue 4, Pages (February 2008)
Transcriptional Regulation by p53 through Intrinsic DNA/Chromatin Binding and Site- Directed Cofactor Recruitment  Joaquin M Espinosa, Beverly M Emerson 
SIRT1 Regulates the Function of the Nijmegen Breakage Syndrome Protein
Mahesh Ramamoorthy, Susan Smith  Cancer Cell 
Volume 43, Issue 5, Pages (September 2011)
Volume 60, Issue 2, Pages (October 2015)
Volume 122, Issue 3, Pages (August 2005)
Volume 55, Issue 1, Pages (July 2014)
Volume 37, Issue 3, Pages (February 2010)
Volume 65, Issue 5, Pages e4 (March 2017)
c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1
Volume 41, Issue 4, Pages (February 2011)
Jörg Hartkamp, Brian Carpenter, Stefan G.E. Roberts  Molecular Cell 
Volume 13, Issue 1, Pages (October 2015)
The interaction of PALB2 with BRCA1 is required for the assembly of PALB2, BRCA2, and RAD51 nuclear foci. The interaction of PALB2 with BRCA1 is required.
Volume 31, Issue 5, Pages (September 2008)
Presentation transcript:

Volume 45, Issue 1, Pages 75-86 (January 2012) Inhibition of Homologous Recombination by the PCNA-Interacting Protein PARI  George-Lucian Moldovan, Donniphat Dejsuphong, Mark I.R. Petalcorin, Kay Hofmann, Shunichi Takeda, Simon J. Boulton, Alan D. D'Andrea  Molecular Cell  Volume 45, Issue 1, Pages 75-86 (January 2012) DOI: 10.1016/j.molcel.2011.11.010 Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 PARI Is a PCNA-Interacting Protein (A) Schematic representation of Srs2 and PARI domain structure (not to scale), and the PARI truncations used for interaction studies. The UvrD, SIM and PIP sequences are shown in Figures S1A–S1C. (B) GST pull-down experiment showing that GST-tagged full-length PARI interacts with PCNA from whole cell extracts of HeLa cells. Recombinant GST-PARI is shown in Figure S1D. (C) GST pull-downs with PARI truncations; the presence of the C-terminal PIP-box of PARI is required for PCNA interaction. (D) Anti-Myc immunoprecipitation from extracts of 293T cells expressing Myc-tagged PARI. Endogenous PCNA co-precipitates with full-length but not PIP-box-deleted PARI. (E) Coimmunoprecipitation of PCNA with Myc-tagged PARI C-terminal constructs required the presence of the PIP-box. (F) The wild-type and a PARI mutant in the hydrophobic patch of the SIM (356LLVL-PAAP, labeled PARIΔSIM) were expressed in 293T cells. Extracts were subjected to GST pull-downs with GST-PCNA and GST-PCNA-SUMO1 fusions (which are shown in Figure S1D). A quantification of the binding strength is shown in Figure S1J. (G–I) PARI interacts with RAD51. (G) GST pull-downs showing that recombinant GST-PARI interacts with endogenous RAD51 from HeLa cell extracts (top), as well as with recombinant RAD51 expressed and purified from bacteria (bottom). (H) In a reciprocal experiment, GST-RAD51 (shown in Figure S1D) was found to interact with Myc-tagged PARI expressed in HeLa cells (top) and with recombinant Flag-tagged PARI purified from insect cells (bottom). The asterisk denotes a cross-reactive band (also in the following panels). (I) RAD51 interacts with the region between amino acids 411 and 487 of PARI. Myc-tagged PARI fragments were expressed in 293T cells and subjected to GST-RAD51 pull-downs. See also Figure S1. Molecular Cell 2012 45, 75-86DOI: (10.1016/j.molcel.2011.11.010) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 2 PARI Is Required for Genomic Stability and Suppression of Homologous Recombination in Human Cells (A) The siRNA sequences employed in this study efficiently downregulate the protein. An antibody raised against PARI can detect exogenously expressed PARI in control but not siRNA-treated cells. The antibody cannot detect endogenous PARI. Real-time PCR experiments confirmed the knockdown of endogenous PARI (Figure S2A). (B) Metaphase spreads of MMC-treated 293T cells shows increased chromosomal aberrations after PARI knockdown. Representative aberrations are marked by arrows. (C) Quantification of chromosomal aberrations in control and PARI-depleted cells. The average of two experiments is shown; at least 50 cells were counted in which experiments. Error bars represent the standard deviation. (D) Crystal violet staining showing that PARI-depleted HeLa cells are sensitive to MMC. (E) HeLa cells treated with siRNA targeting PARI show decreased cellular survival in the presence of MMC for 3 days. The average of two experiments is presented; error bars represent the standard deviation. (F) Knockdown of PARI leads to increased homologous recombination, as measured with a direct-repeat recombination assay (DR-GFP) in U2OS cells. Two to five independent experiments were averaged; standard deviations are shown as error bars. See also Figure S2. Molecular Cell 2012 45, 75-86DOI: (10.1016/j.molcel.2011.11.010) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 3 Hyperrecombination Phenotype of Chicken DT40 PARI−/− Cells (A) Graphic representation of the PARI gene locus on chicken chromosome 1. Also shown are insertion sites for the targeting cassette, the positions for the Southern blot probe, and the RT-PCR primers used to detect the knockout alleles. (B) Southern blot analysis of the DT40 cell lines obtained, confirming the PARI knockout. (C) RT-PCR showing the loss of messenger RNA for PARI in the knockout cell line. (D) DT40-specific gene conversion assay (SCneo) showing that direct repeat recombination is increased in the absence of PARI. The average of at least two independent experiments is shown, with error bars representing the standard deviation. (E) Sister chromatid exchanges in wild-type and PARI−/− DT40 cells. At least 50 cells were analyzed for each condition. Another representation of this result is shown in Figures S3A and S3B. (F) Representative micrograph showing increased Camptothecin-induced RAD51 foci in DT40 cells with PARI deletion. Data quantification is presented in (G). (G) Quantification of RAD51 foci in DT40 cells after treatment with 100 nM Camptothecin. Cells were washed, released in normal media and analyzed at the time points indicated. Two experiments, with at least 40 to 125 cells analyzed for each situation, were averaged; error bars represent the standard deviation. (H) RAD51 foci are increased in DT40 PARI−/− cells after IR exposure; introduction of human PARI corrects this phenotype. See quantification in (I). (I) Representation of RAD51 foci in DT40 cells treated with 4γray IR. Cells were analyzed at the indicated time points after radiation. The average of two experiments is shown. For each condition, 35 to 100 cells were analyzed; error bars represent the standard deviation. See also Figure S3. Molecular Cell 2012 45, 75-86DOI: (10.1016/j.molcel.2011.11.010) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 4 PARI Functions Require PCNA Interaction (A) Western blot showing the stable expression of human PARI, either full-length or lacking the C-terminal PIP-box, in chicken DT40 PARI−/− cells. (B) Wild-type, but not the PIP-box deletion (lacking amino acids 571 to 579) or the SIM mutant, can restore Camptothecin resistance in PARI-knocked-out DT40 cells. Cellular survival was measured after growth for 4 days in the presence of the indicated Camptothecin amounts. Two independent experiments were averaged; error bars represent the standard error. (C and D) Fractionation of extracts of HeLa cells transfected with wild-type or PIP-box-deleted Myc-tagged PARI and treated with 1 mM hydroxyurea for 12 hr. The PCNA interaction-deficient PARI variant does not correctly localize to chromatin. Anti-Myc western blotting was used to detect the localization of exogenous PARI in fractionated extracts (C). As control for fractionation, an anti-FANCD2 blot, showing the exclusive chromatin localization of the ubiquitinated form, is also presented (bottom). Quantification of this result is shown in (D). Bars represent the percentage of PARI protein present in different fractions, as averaged from two experiments; error bars represent the standard deviation. See also Figure S4. Molecular Cell 2012 45, 75-86DOI: (10.1016/j.molcel.2011.11.010) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 5 Disruption of RAD51 Nucleofilaments by PARI In Vitro (A) The PARI preparation used for in vitro assays. The protein was purified from baculovirus-infected insect cells. (B) PARI has no ATPase activity. Shown is quantification of ATP hydrolysis by PARI and RecA as positive control, averaged from two independent experiments; error bars represent the standard deviation. A representative experiment is shown is Figure S5. (C) Schematic representation of the ssDNA-RAD51 filament disruption assay. (D and E) PARI removes RAD51 from ssDNA. (D) Autoradiograph of RAD51 nucleofilaments formed by incubation of recombinant RAD51 with radiolabeled ssDNA. Subsequent addition of PARI results in release of RAD51 from DNA. (E) Quantification of the ssDNA-RAD51 filament disruption result shown in (D). (F and G) ATP hydrolysis is required for RAD51 displacement by PARI. (F) Autoradiograph showing RAD51 ssDNA nucleofilaments formed in the presence of ATP or AMP-PMP. Addition of PARI only disrupted RAD51 filaments formed in the presence of ATP. (G) Quantification of the result shown in (F). See also Figure S5. Molecular Cell 2012 45, 75-86DOI: (10.1016/j.molcel.2011.11.010) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 6 Improved Genomic Stability in BRCA2-Deficient Cells after PARI Depletion (A) Representation of chromosomal aberrations quantified from metaphase spreads of BRCA2-deficient VU423 cells (labeled BRCA2–). Cells were treated with control or siRNA targeting PARI and incubated for 3 days with 5 ng/ml MMC. As control, VU423 cells in which BRCA2 cDNA was transfected were used. Two independent experiments were averaged; for each condition, at least 50 cells analyzed. Error bars represent the standard deviation. The quantification of radial chromosomes is shown in Figure S5A. (B) Sensitivity to PARP-1 inhibitor AZD2281 of VU423 cells is alleviated by PARI knockdown or by BRCA2 reintroduction. The average of two experiments is presented; error bars represent the standard deviation. (C) Baseline and IR-induced RAD51 foci are increased in VU423 cells after PARI depletion. Cells were analyzed at the indicated time points after exposure to 8γray IR. At least 30 cells were analyzed for each condition. The average of two experiments is presented; error bars represent the standard deviation. (D) Direct repeat recombination was measured in U2OS cells with the DR-GFP reporter. PARI knockdown partly alleviated the severe HR defect caused by BRCA2 depletion. The average of five independent experiments is presented; error bars represent the standard error. See also Figure S6. Molecular Cell 2012 45, 75-86DOI: (10.1016/j.molcel.2011.11.010) Copyright © 2012 Elsevier Inc. Terms and Conditions